Trial intelligence / Profile preview

Dexmedetomidine Sedation for Third Molar Extraction

NCT01017237Phase 4Terminated

Sponsor
University of North Carolina at Chapel Hill
Start
Jul 2009
Primary completion
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dexmedetomidine in Procedural sedation (PS), sponsored by University of North Carolina at Chapel Hill. Started Jul 2009; status: terminated.

02

Drugs

dexmedetomidine
03

Conditions

Procedural sedation (PS)

Beyond the preview

Go deeper on NCT01017237.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01017237.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call